▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁s 9.609375
E 9.3359375
vere 8.203125
▁pain 1.6728515625
kill 4.02734375
ers 0.00899505615234375
. 0.666015625
▁It 3.357421875
▁comp 5.42578125
ares 0.059539794921875
▁the 0.65576171875
▁effic 6.21484375
acy 0.0110321044921875
▁of 0.25830078125
▁pres 5.12109375
cri 1.8759765625
ptions 0.75927734375
▁and 2.330078125
▁exam 6.09375
ines 0.01338958740234375
▁the 0.46484375
▁possibility 3.94921875
▁of 0.10614013671875
▁post 7.28515625
- 0.76171875
tre 2.408203125
at 0.0200347900390625
ment 0.01302337646484375
▁de 1.9521484375
pression 0.094970703125
. 1.775390625
<0x0A> 2.41015625
There 4.921875
▁is 1.0361328125
▁currently 4.546875
▁a 1.177734375
▁severe 5.03125
▁lack 3.2421875
▁of 0.027496337890625
▁information 2.107421875
▁about 1.4443359375
▁the 0.491455078125
▁effects 2.88671875
▁of 0.07281494140625
▁op 1.7685546875
i 3.994140625
ates 0.1513671875
. 3.8671875
▁They 4.94140625
▁man 13.9140625
a 4.2265625
Ge 5.56640625
▁pain 3.44921875
▁successfully 7.7109375
, 1.216796875
▁but 0.426513671875
▁the 2.60546875
▁past 9.640625
▁few 2.474609375
▁dec 0.8271484375
ades 0.0028285980224609375
▁indicated 9.15625
▁the 2.1953125
▁growing 4.6953125
▁concern 3.431640625
▁regarding 3.203125
▁op 3.439453125
iate 0.8369140625
▁ab 1.5732421875
use 0.013671875
▁in 3.30859375
▁forms 10.7109375
▁of 0.395751953125
▁over 3.36328125
d 0.412109375
ose 0.1597900390625
▁and 0.71142578125
▁add 1.1337890625
iction 0.032379150390625
. 0.236083984375
▁A 3.953125
▁more 5.73828125
▁manage 8.6640625
able 0.01154327392578125
▁and 2.3125
▁sa 2.251953125
fer 0.0028858184814453125
▁alternative 1.650390625
▁might 6.48828125
▁be 0.1839599609375
▁medical 2.80859375
▁mar 0.1856689453125
iju 0.01448822021484375
ana 0.006206512451171875
. 1.5595703125
▁However 2.94921875
, 0.0110931396484375
▁the 1.6328125
▁legal 4.28515625
▁status 1.1865234375
▁and 2.755859375
▁novel 9.2265625
ty 0.69189453125
▁of 0.197021484375
▁this 1.6337890625
▁drug 2.103515625
▁do 5.03515625
▁not 0.08477783203125
▁allow 1.044921875
▁finding 8.8203125
▁a 2.2890625
▁large 4.1953125
▁number 1.3603515625
▁of 0.007495880126953125
▁studies 1.359375
▁on 1.53515625
▁its 0.9912109375
▁effect 2.216796875
iveness 0.439208984375
. 1.0234375
▁Specifically 8.0546875
, 0.12152099609375
▁it 2.6875
▁concerns 4.84765625
▁the 0.62890625
▁emot 7.41796875
ional 0.0191497802734375
▁condition 5.37890625
▁of 0.388916015625
▁patients 0.70751953125
▁experien 6.265625
cing 0.0021305084228515625
▁chron 0.94140625
ic 0.004352569580078125
▁pain 0.10589599609375
. 0.67578125
▁This 3.162109375
▁research 2.970703125
▁paper 6.3046875
▁a 2.25
ims 0.0021152496337890625
▁to 0.09625244140625
▁analyze 3.099609375
▁levels 9.640625
▁of 0.035491943359375
▁de 0.55859375
pression 0.03900146484375
▁and 0.251708984375
▁anx 0.04449462890625
iety 0.0031280517578125
▁among 0.74560546875
▁people 3.39453125
▁receiving 0.908203125
▁ther 7.7578125
apy 0.33349609375
▁by 5.140625
▁comparing 7.9296875
▁the 1.0078125
▁effects 2.166015625
▁of 0.0305938720703125
▁ph 2.5390625
arma 0.059295654296875
ce 0.0021266937255859375
ut 0.0013380050659179688
ical 0.00392913818359375
▁op 0.29931640625
io 0.1759033203125
ids 0.06634521484375
▁and 0.267578125
▁MM 1.701171875
. 0.90966796875
<0x0A> 1.1142578125
The 1.4072265625
▁study 2.197265625
▁was 2.1796875
▁conducted 0.76025390625
▁in 1.5927734375
▁the 1.4248046875
▁form 2.205078125
▁of 0.01403045654296875
▁collection 10.1171875
▁and 1.6591796875
▁analysis 0.68408203125
▁of 0.043365478515625
▁statistical 4.171875
▁data 0.125
. 0.96484375
▁Part 4.94921875
icip 0.0792236328125
ants 0.0528564453125
▁were 0.7529296875
▁rec 3.380859375
ru 0.002285003662109375
ited 0.0006756782531738281
▁for 4.08984375
▁six 7.63671875
▁months 0.5283203125
▁at 3.830078125
▁two 2.533203125
▁major 5.5625
▁pain 3.298828125
▁relief 5.20703125
▁cent 1.4990234375
ers 0.08551025390625
▁in 0.70556640625
▁Israel 4.3671875
. 0.437255859375
▁The 1.2109375
▁research 2.173828125
ers 1.4599609375
▁used 2.638671875
▁The 7.76953125
▁De 4.1796875
pression 0.0159759521484375
▁Module 9.9453125
▁of 0.96484375
▁the 0.31787109375
▁Pat 2.34375
ient 0.00817108154296875
▁Health 0.0865478515625
▁Question 0.017303466796875
naire 0.02294921875
▁and 3.39453125
▁the 0.72412109375
▁General 1.7314453125
ized 0.72509765625
▁An 0.017303466796875
x 0.0003616809844970703
iety 0.00350189208984375
▁Dis 0.52783203125
order 0.038177490234375
▁Sc 1.255859375
ale 0.071044921875
▁to 1.7666015625
▁interview 7.01953125
▁participants 2.013671875
, 3.703125
▁evaluate 5.4609375
▁their 0.7353515625
▁answers 6.5546875
, 0.8837890625
▁and 0.1519775390625
▁conduct 4.42578125
▁the 2.333984375
▁study 2.3125
. 0.230224609375
▁To 5.07421875
▁specifically 9.9609375
▁evaluate 2.5234375
▁and 4.359375
▁compare 0.95849609375
▁the 0.33251953125
▁prob 11.125
abilities 0.2318115234375
▁of 0.1304931640625
▁de 0.8125
pression 0.0413818359375
▁or 4.6171875
▁anx 0.040802001953125
iety 0.000812530517578125
▁among 1.6875
▁the 2.291015625
▁diverse 9.015625
▁groups 1.583984375
, 1.52734375
▁the 1.0205078125
▁study 2.73046875
▁used 1.5849609375
▁multiple 4.6796875
▁log 2.900390625
istic 0.040679931640625
▁regression 0.099609375
▁analysis 0.67138671875
▁and 2.533203125
▁chose 8.9453125
▁medical 7.52734375
▁mar 0.366943359375
iju 0.00421142578125
ana 0.0011625289916992188
▁as 0.7958984375
▁the 1.10546875
▁control 2.6171875
▁group 0.56396484375
. 0.287109375
<0x0A> 0.8046875
This 3.4921875
▁type 6.07421875
▁of 0.0098724365234375
▁study 1.751953125
▁is 1.2255859375
▁the 3.361328125
▁most 1.876953125
▁reve 9.03125
aling 0.0021419525146484375
▁and 1.0419921875
▁inclus 6.54296875
ive 0.00333404541015625
, 2.279296875
▁as 1.8759765625
▁it 0.3466796875
▁contains 4.8828125
▁direct 6.390625
▁responses 5.046875
▁from 0.8056640625
▁a 3.919921875
▁large 0.92578125
▁number 0.44287109375
▁of 0.004627227783203125
▁participants 1.4501953125
. 0.64404296875
▁All 4.6171875
▁tools 9.0625
▁in 4.51953125
▁the 0.685546875
▁form 3.505859375
▁of 0.040985107421875
▁question 1.76171875
na 0.0341796875
ires 0.00043392181396484375
▁and 2.1015625
▁scales 3.11328125
▁have 3.640625
▁already 4.45703125
▁been 0.1705322265625
▁used 1.9248046875
▁and 2.115234375
▁proved 4.1953125
▁their 1.7265625
▁effic 3.853515625
acy 0.00025010108947753906
▁for 3.677734375
▁collect 4.58984375
ing 0.018402099609375
▁analyt 8.2421875
ical 0.2469482421875
▁data 0.268310546875
. 0.420166015625
▁It 3.5546875
▁helps 4.89453125
▁to 0.91943359375
▁system 7.26171875
at 1.265625
ize 0.01432037353515625
▁and 1.578125
▁class 4.08203125
ify 0.0028228759765625
▁distinct 9.3203125
▁kinds 6.26953125
▁of 0.025787353515625
▁information 3.505859375
▁for 3.921875
▁subsequent 4.01171875
▁un 7.97265625
comp 5.515625
licated 0.06939697265625
▁services 11.703125
. 0.64404296875
▁Thus 4.33984375
, 0.02435302734375
▁research 4.48046875
ers 0.5244140625
▁can 1.359375
▁compare 3.994140625
▁the 0.95556640625
▁effects 3.01953125
▁of 0.10406494140625
▁medic 4.3359375
ations 0.8720703125
▁on 1.7626953125
▁patients 2.109375
▁of 4.5
▁diverse 4.296875
▁age 2.708984375
▁groups 0.66357421875
, 0.921875
▁background 5.06640625
s 0.21923828125
, 0.07110595703125
▁physical 5.4140625
▁conditions 1.375
, 0.08978271484375
▁emot 5.47265625
ional 0.0687255859375
▁states 1.3701171875
, 0.10546875
▁and 0.44287109375
▁so 3.173828125
▁on 0.314697265625
. 0.09454345703125
<0x0A> 0.681640625
The 1.111328125
▁analysis 4.52734375
▁of 0.5537109375
▁any 8.875
▁human 6.0390625
▁reaction 4.8359375
▁has 4.6015625
▁a 1.7158203125
▁high 4.47265625
▁potential 3.462890625
▁of 1.67578125
▁subject 6.00390625
iveness 3.91015625
▁and 1.34375
▁bias 2.248046875
, 1.900390625
▁especially 2.451171875
▁regarding 4.47265625
▁people 4.5
▁in 4.0078125
▁severe 4.61328125
▁pain 0.40185546875
▁and 2.5859375
▁un 5.34375
stable 1.8486328125
▁emot 0.80859375
ional 0.175048828125
▁condition 2.4921875
. 0.073974609375
▁Perhaps 8.8828125
▁some 4.9609375
▁patients 2.359375
▁tend 5.66015625
▁to 0.022186279296875
▁ex 2.52734375
agger 0.0018815994262695312
ate 0.006969451904296875
▁their 0.7431640625
▁de 5.03125
press 1.4150390625
ive 0.278076171875
▁state 3.09375
▁or 1.845703125
▁vice 7.390625
▁vers 0.01473236083984375
a 0.0003407001495361328
, 1.0078125
▁de 7.41796875
- 4.72265625
emph 1.0
as 0.006969451904296875
ize 0.1412353515625
▁serious 6.6328125
▁difficulties 5.9375
. 0.88330078125
▁Because 6.171875
▁the 2.30078125
▁survey 6.12890625
▁responses 6.62890625
▁were 1.6083984375
▁thoroughly 7.8984375
▁anonymous 5.29296875
, 0.4541015625
▁the 1.4619140625
▁research 1.515625
ers 0.26611328125
▁were 1.4423828125
▁unable 2.37890625
▁to 0.0050811767578125
▁carefully 8.7109375
▁analyze 1.568359375
▁each 3.96484375
▁patient 2.49609375
’ 27.0
s 0.79296875
▁reaction 3.705078125
▁and 2.37109375
▁compare 3.494140625
▁it 0.8984375
▁to 1.2646484375
▁the 0.76318359375
▁actual 5.70703125
▁states 7.2734375
▁of 0.69677734375
▁condition 7.21484375
. 0.3876953125
▁More 6.875
▁accurate 3.796875
▁answers 4.6953125
▁could 2.474609375
▁be 0.89306640625
▁obtained 0.9853515625
▁by 1.3857421875
▁professional 7.46875
▁psych 2.1640625
olog 0.320556640625
ists 0.00252532958984375
▁via 7.96484375
▁personal 3.92578125
▁communication 4.6953125
▁and 1.83203125
▁behavior 7.16015625
al 0.33642578125
▁analysis 2.224609375
. 0.2276611328125
▁However 2.74609375
, 0.0027980804443359375
▁this 1.9306640625
▁method 2.841796875
▁of 2.28125
▁research 2.12109375
▁is 0.9248046875
▁way 7.85546875
▁more 1.69921875
▁resource 6.57421875
- 0.422607421875
int 0.54541015625
ensive 0.009246826171875
▁and 0.62353515625
▁energy 8.6171875
- 0.1171875
consum 0.31640625
ing 0.0023059844970703125
. 0.58642578125
<0x0A> 0.65380859375
Part 5.546875
icip 0.09466552734375
ants 0.1148681640625
▁were 1.021484375
▁rec 1.560546875
ru 0.001468658447265625
ited 0.0002027750015258789
▁for 1.1484375
▁six 1.2216796875
▁months 0.02398681640625
▁at 0.463623046875
▁two 0.114990234375
▁major 0.356689453125
▁pain 0.0377197265625
▁relief 0.029693603515625
▁cent 0.0311279296875
ers 0.00949859619140625
▁in 0.0626220703125
▁Israel 0.03338623046875
. 0.1490478515625
▁All 3.4921875
▁patients 1.5576171875
▁experienced 5.4296875
▁chron 1.46484375
ic 0.0028133392333984375
▁pain 0.09814453125
▁for 3.400390625
▁at 0.7392578125
▁least 0.0014047622680664062
▁ 1.0712890625
3 1.4658203125
▁months 0.236572265625
. 1.0205078125
▁The 1.474609375
▁study 1.966796875
▁included 2.166015625
▁ 1.1181640625
8 2.884765625
9 2.76171875
0 3.615234375
▁participants 1.50390625
, 1.2431640625
▁of 1.755859375
▁which 0.4013671875
▁ 0.1470947265625
4 1.6103515625
7 2.466796875
4 2.751953125
▁( 2.18359375
5 0.0980224609375
9 11.1171875
%) 1.0400390625
▁were 0.473876953125
▁treated 4.60546875
▁sole 6.9375
ly 0.00014710426330566406
▁with 0.47216796875
▁op 0.7724609375
io 0.38916015625
ids 0.1947021484375
, 1.1572265625
▁ 0.60546875
3 1.076171875
2 2.091796875
9 2.55859375
▁( 0.043975830078125
4 1.1474609375
1 1.228515625
%) 0.1361083984375
▁were 1.302734375
▁treated 0.51953125
▁with 0.1800537109375
▁MM 0.77685546875
, 0.22705078125
▁and 0.137451171875
▁ 0.1412353515625
7 3.244140625
7 2.419921875
▁( 0.169921875
8 3.83203125
. 1.1416015625
6 3.041015625
%) 0.057220458984375
▁acquired 9.609375
▁both 1.1787109375
▁( 7.0390625
Fe 10.21875
ing 3.544921875
old 0.0157928466796875
▁et 1.4775390625
▁al 0.0213470458984375
., 0.3056640625
▁ 0.01152801513671875
2 0.1658935546875
0 0.0006771087646484375
1 0.392333984375
7 2.048828125
). 0.134765625
▁The 1.3466796875
▁remaining 6.95703125
▁ten 8.09375
▁participants 1.37890625
▁who 5.578125
▁did 1.49609375
▁not 0.007343292236328125
▁receive 1.806640625
▁ph 3.09375
arma 0.05987548828125
ce 0.0017576217651367188
ut 0.00010657310485839844
ical 0.0034332275390625
▁op 1.017578125
io 0.07843017578125
ids 0.0225067138671875
▁and 1.66015625
▁medical 2.353515625
▁mar 0.045166015625
iju 0.005527496337890625
ana 0.0001226663589477539
▁were 1.236328125
▁with 6.0625
dra 0.1416015625
wn 0.00018668174743652344
▁from 0.251953125
▁the 0.10858154296875
▁analysis 4.63671875
▁in 4.82421875
▁the 1.1865234375
▁research 4.2421875
. 0.7431640625
▁Therefore 4.79296875
, 0.007843017578125
▁it 3.7890625
▁is 0.892578125
▁not 2.705078125
▁possible 0.6435546875
▁to 0.01971435546875
▁compreh 6.53515625
ens 0.048980712890625
ively 0.01274871826171875
▁compare 1.888671875
▁patients 4.78125
▁taking 4.328125
▁medic 3.77734375
ations 0.4599609375
▁with 0.9599609375
▁those 1.126953125
▁who 1.1181640625
▁do 1.716796875
▁not 0.00858306884765625
. 0.794921875
<0x0A> 0.65087890625
The 1.1318359375
▁study 1.7353515625
▁conducted 4.71875
▁a 2.107421875
▁correlation 5.9453125
▁type 7.375
▁of 0.44091796875
▁research 2.021484375
▁with 2.849609375
▁variable 7.97265625
▁measures 4.55078125
. 1.244140625
▁It 2.123046875
▁evaluated 4.36328125
▁the 0.5703125
▁inter 6.27734375
dep 3.62109375
end 0.0007872581481933594
ence 0.011138916015625
▁of 0.57861328125
▁various 3.884765625
▁factors 1.603515625
▁that 2.830078125
▁affected 4.2265625
▁the 0.57421875
▁physical 6.890625
▁and 1.001953125
▁emot 0.4716796875
ional 0.0004477500915527344
▁condition 1.013671875
▁of 0.1080322265625
▁patients 0.6142578125
▁experien 4.1875
cing 9.465217590332031e-05
▁chron 0.444580078125
ic 0.0004863739013671875
▁pain 0.025604248046875
. 0.2183837890625
▁For 3.830078125
▁example 1.0849609375
, 0.015625
▁the 1.2138671875
▁survey 5.15234375
▁showed 3.349609375
▁that 0.40966796875
▁the 1.744140625
▁ratio 6.9453125
▁of 0.122314453125
▁female 4.4375
▁patients 0.7734375
▁was 1.8779296875
▁remark 9.5703125
ably 0.001003265380859375
▁higher 0.5234375
▁in 2.69921875
▁the 0.9609375
▁op 4.5234375
i 4.01953125
ates 0.10321044921875
▁group 0.285400390625
▁compared 2.736328125
▁to 0.11456298828125
▁the 0.50146484375
▁MM 0.5400390625
▁group 0.294677734375
. 0.4873046875
▁In 2.9765625
▁turn 4.0
, 0.0029926300048828125
▁people 5.953125
▁on 5.50390625
▁op 1.373046875
i 0.440673828125
ates 0.00373077392578125
▁were 1.0615234375
▁more 0.98681640625
▁likely 0.387939453125
▁to 0.05999755859375
▁report 3.1953125
▁major 5.96484375
▁de 0.392822265625
press 1.20703125
ive 0.004367828369140625
▁dis 0.5029296875
orders 1.3369140625
. 1.76953125
<0x0A> 2.515625
The 1.1259765625
▁question 5.75
na 1.248046875
ires 0.000194549560546875
▁used 2.0
▁different 8.1796875
▁variable 8.7421875
▁measures 0.794921875
▁to 1.3515625
▁collect 2.34375
▁information 1.9521484375
. 1.6240234375
▁For 1.95703125
▁example 0.1976318359375
, 0.007686614990234375
▁it 4.0390625
▁included 2.482421875
▁compreh 8.6328125
ensive 0.027313232421875
▁so 6.828125
cio 0.0259857177734375
- 0.4892578125
dem 0.0921630859375
ographic 0.038543701171875
▁data 1.00390625
: 4.88671875
▁gender 1.5849609375
, 0.0919189453125
▁age 0.20947265625
, 0.08935546875
▁country 4.33203125
, 1.4609375
▁type 4.375
▁of 0.05755615234375
▁residence 3.87109375
▁( 3.48828125
urban 2.017578125
/ 2.927734375
r 0.0634765625
ural 0.000873565673828125
), 0.2391357421875
▁years 5.953125
▁of 0.1644287109375
▁education 0.6767578125
, 0.1484375
▁and 1.8515625
▁employ 3.671875
ment 0.00452423095703125
▁status 0.443603515625
. 0.177978515625
▁Pat 4.1015625
ients 0.096923828125
▁were 1.173828125
▁also 0.8525390625
▁asked 0.62353515625
▁about 1.142578125
▁their 0.6162109375
▁medical 2.76171875
▁history 0.408935546875
▁over 8.8125
▁the 0.156982421875
▁years 3.9921875
▁and 1.8046875
▁the 1.83984375
▁current 3.353515625
▁presence 5.89453125
▁of 0.05279541015625
▁any 2.666015625
▁severe 4.87109375
▁dise 1.51953125
ases 0.00010645389556884766
▁such 4.20703125
▁as 0.004428863525390625
▁heart 2.41015625
▁failure 2.041015625
, 0.191650390625
▁di 1.84765625
ab 0.001983642578125
etes 0.004528045654296875
, 0.12493896484375
▁ar 3.8203125
th 0.1285400390625
rit 0.03411865234375
is 0.012298583984375
, 0.041900634765625
▁and 1.5751953125
▁so 0.7265625
▁on 0.031463623046875
. 0.0526123046875
▁The 1.8896484375
▁third 7.16796875
▁measure 3.9375
▁of 2.05859375
▁the 1.0009765625
▁question 2.853515625
naire 0.170654296875
▁was 0.97216796875
▁indicated 9.7265625
▁by 0.638671875
▁information 6.5859375
▁on 1.5810546875
▁any 5.37890625
▁twelve 13.640625
- 1.1455078125
month 0.359130859375
▁and 5.8125
▁lifetime 3.19921875
▁drug 4.71484375
▁and 3.478515625
▁alco 0.07940673828125
hol 0.0001024007797241211
▁consumption 2.578125
. 0.462158203125
▁In 3.494140625
▁addition 0.796875
, 0.1268310546875
▁the 1.1640625
▁record 7.82421875
▁included 1.73828125
▁a 2.48828125
▁pain 6.390625
▁measurement 4.2421875
▁scale 1.0322265625
▁from 3.654296875
▁ 0.465576171875
0 0.44189453125
▁to 0.424072265625
▁ 0.00710296630859375
1 0.0887451171875
0 0.07501220703125
▁to 4.63671875
▁evaluate 1.5498046875
▁dis 5.94140625
com 0.213623046875
fort 0.00171661376953125
▁feelings 7.29296875
▁during 3.3046875
▁the 0.91259765625
▁last 1.4697265625
▁month 1.580078125
. 0.280029296875
<0x0A> 1.1279296875
Am 6.90625
ong 0.01345062255859375
▁all 2.37109375
▁participants 1.9892578125
▁in 3.546875
▁the 0.1741943359375
▁study 0.376220703125
, 0.05609130859375
▁ 0.67041015625
4 1.759765625
2 2.728515625
. 1.7744140625
2 2.294921875
% 0.147216796875
▁suffered 4.86328125
▁from 0.129638671875
▁de 1.7509765625
pression 0.1673583984375
, 1.080078125
▁and 1.7734375
▁ 0.1474609375
3 1.71875
7 2.232421875
% 2.736328125
▁experienced 2.302734375
▁excess 7.79296875
ive 0.08740234375
▁anx 0.264404296875
iety 0.001827239990234375
. 0.345947265625
▁The 1.421875
▁pl 11.15625
ur 1.0107421875
ality 0.00020360946655273438
▁of 0.19384765625
▁de 3.521484375
press 1.2431640625
ive 0.023590087890625
▁dis 1.8017578125
orders 0.059173583984375
▁among 3.79296875
▁patients 1.177734375
▁in 3.62109375
▁the 0.360107421875
▁op 1.416015625
i 0.95068359375
ates 0.0051116943359375
, 7.15234375
▁medical 2.947265625
▁mar 0.0209808349609375
iju 0.00702667236328125
ana 4.565715789794922e-05
, 0.108642578125
▁and 0.0621337890625
▁mixed 6.02734375
▁OP 8.78125
MM 6.11328125
▁groups 0.459228515625
▁number 8.03125
ed 0.0099639892578125
▁ 0.12127685546875
5 2.185546875
7 2.48046875
. 0.201171875
1 2.3671875
%, 0.2462158203125
▁ 0.004352569580078125
2 3.013671875
2 2.4375
. 0.103515625
3 2.23046875
%, 0.11370849609375
▁and 0.0328369140625
▁ 0.002910614013671875
5 3.212890625
1 2.548828125
. 0.16552734375
4 2.14453125
%, 0.38818359375
▁respectively 0.0100555419921875
. 0.284912109375
▁The 1.46875
▁pl 4.625
ur 0.022705078125
ality 3.3736228942871094e-05
▁of 0.04071044921875
▁anx 0.931640625
iety 0.01111602783203125
▁contained 11.0
▁ 0.568359375
4 1.58203125
8 2.375
. 0.06256103515625
4 2.30859375
% 0.492431640625
▁among 1.4580078125
▁OP 6.53125
▁patients 9.15625
, 0.273193359375
▁ 0.096435546875
2 1.490234375
1 2.416015625
. 0.13134765625
5 2.431640625
% 0.01129150390625
▁among 0.421142578125
▁MM 0.32666015625
▁patients 0.2509765625
, 0.011260986328125
▁and 0.01316070556640625
▁ 0.03729248046875
3 1.232421875
8 2.6484375
. 0.156005859375
7 2.29296875
% 0.01335906982421875
▁among 0.2362060546875
▁OP 4.20703125
MM 0.22216796875
▁participants 3.560546875
. 0.2230224609375
▁Pat 5.8125
ients 0.021759033203125
▁who 2.390625
▁took 2.916015625
▁strong 8.2734375
▁op 1.2734375
i 1.373046875
ates 0.0033721923828125
▁were 1.75
▁t 8.8984375
ended 1.1416015625
▁to 0.012969970703125
▁place 10.328125
▁their 3.69140625
▁pain 2.580078125
▁on 3.35546875
▁a 0.87255859375
▁scale 2.341796875
▁of 0.640625
▁ 0.354248046875
9 2.810546875
▁to 1.3818359375
▁ 0.01555633544921875
1 0.0232086181640625
0 0.092529296875
▁( 2.5703125
Fe 1.6982421875
ing 0.00923919677734375
old 0.0005078315734863281
▁et 0.0301971435546875
▁al 0.0010519027709960938
., 0.006961822509765625
▁ 0.0016260147094726562
2 0.0005393028259277344
0 5.0067901611328125e-05
1 0.0018320083618164062
7 0.01264190673828125
). 0.051055908203125
▁They 4.6953125
▁were 1.2587890625
▁also 1.3720703125
▁an 8.8515625
gu 4.49609375
ished 0.03826904296875
▁em 8.484375
otion 0.0123291015625
ally 0.003757476806640625
▁and 1.103515625
▁react 6.83984375
ed 0.0579833984375
▁rad 9.484375
ically 0.0036830902099609375
▁neg 5.38671875
atively 0.0011539459228515625
▁to 0.344970703125
▁almost 5.2109375
▁all 1.197265625
▁survey 8.4375
▁questions 0.62158203125
. 0.2861328125
▁Pat 4.23046875
ients 0.00756072998046875
▁who 1.1513671875
▁took 1.5185546875
▁only 5.41796875
▁MM 0.94287109375
▁or 3.205078125
▁mixed 3.431640625
▁medic 2.55859375
ations 0.32666015625
▁course 12.7578125
▁had 2.458984375
▁a 1.2705078125
▁significantly 2.556640625
▁more 4.07421875
▁stable 3.421875
▁emot 1.2021484375
ional 0.0072784423828125
▁state 0.8154296875
▁and 1.4072265625
▁cop 5.5859375
ed 0.818359375
▁with 0.72998046875
▁pain 1.513671875
▁more 1.6396484375
▁manage 6.9453125
able 2.451171875
. 0.52734375
<0x0A> 0.70458984375
One 5.16796875
▁of 0.59765625
▁the 0.0175018310546875
▁major 2.548828125
▁limitations 2.703125
▁is 3.8984375
▁the 0.51513671875
▁ins 4.71875
u 0.0175323486328125
fficient 0.12353515625
ly 4.71484375
▁high 2.986328125
▁response 3.009765625
▁rate 0.11700439453125
, 2.681640625
▁ 4.63671875
5 1.9140625
7 2.037109375
% 2.12890625
▁instead 7.328125
▁of 0.005725860595703125
▁ 0.70166015625
7 1.515625
0 1.46484375
% 1.1259765625
▁( 1.6103515625
Fe 0.2666015625
ing 0.00428009033203125
old 0.0005970001220703125
▁et 0.00661468505859375
▁al 0.0006918907165527344
., 0.00472259521484375
▁ 0.0012750625610351562
2 0.00041365623474121094
0 2.300739288330078e-05
1 0.00091552734375
7 0.006305694580078125
). 0.03759765625
▁It 2.66796875
▁can 3.248046875
▁be 0.40185546875
▁fairly 8.34375
▁explained 1.453125
▁by 0.1697998046875
▁the 0.3271484375
▁weak 8.2421875
▁focus 7.12890625
▁of 0.46826171875
▁respond 6.27734375
ents 0.1314697265625
▁who 3.51171875
▁have 4.046875
▁overcome 8.0703125
▁severe 2.322265625
▁pain 0.58251953125
▁sens 8.671875
ations 1.0986328125
▁and 1.18359375
▁de 4.13671875
press 1.7099609375
ive 0.24560546875
▁episodes 3.947265625
. 0.6064453125
▁It 3.349609375
▁is 0.81884765625
▁not 2.65234375
▁clear 4.23046875
▁how 1.6728515625
▁to 3.564453125
▁use 5.39453125
▁these 3.044921875
▁statistics 3.37890625
, 2.572265625
▁as 1.4228515625
▁they 1.357421875
▁still 6.13671875
▁may 4.83984375
▁be 1.328125
▁relevant 5.3046875
▁for 1.39453125
▁the 1.861328125
▁overall 4.47265625
▁analysis 3.044921875
. 1.0751953125
